Skip to main content
Back to Perspectives on China blog

Franck Le Deu

Senior Partner, Hong Kong
Helps healthcare multinationals capture opportunities in China, Asia, and emerging markets, with a focus on improving commercial operations and business expansion

Posts By Franck Le Deu

Browse by:

China has become a CEO-level priority for multinational pharma companies

After a hot period of rapid growth from 2009 to 2012 and a relatively cooler period of slower growth from 2013 to 2015, China has once again become a top-of-mind priority for the CEOs of most large, multinational pharmaceutical companies.

Investors are plowing billions of dollars into China’s rapidly growing healthcare market. Here’s why

China’s healthcare market is ripe for expansion as capital investment soars and the regulatory environment remains stable.